Kingfish delivered a 10.2% gross return in the six months to September, but its shares ended the quarter at a 15.5% discount to NAV. The investment company also added Skellerup to its portfolio as Delegat, Vista and Fisher & Paykel Healthcare led quarterly gains.
- 10.2% gross portfolio return for the six months to September
- 1.3% quarterly gross return versus 1.6% for the S&P/NZX50G
- Shares ended at a 15.5% discount to $1.26 NAV per share
- Skellerup added to the portfolio and contributed positively
- Quarterly dividend of 2.50 cents per share paid in September
Portfolio gains outpace the benchmark over six months
Kingfish Limited (NZX:KFL) produced a 10.2% gross portfolio return in the six months to 30 September 2026, ahead of the S&P/NZX50G’s 7.1% gain. The September quarter itself was more subdued: gross performance rose 1.3%, while adjusted NAV increased 0.9%, below the benchmark’s 1.6% return.
The result gives Kingfish a useful split-screen performance story. Its underlying portfolio continued to add value over the half-year, while the latest quarter lagged the market and the company’s share price remained under pressure. Kingfish’s earlier August portfolio gains had also been led by Vista, Fisher & Paykel Healthcare and Delegat.
Share price discount reaches 15.5% of NAV
Kingfish shares ended September at $1.07 against a net asset value of $1.26 per share, representing a 15.5% discount. The company said it bought shares on market during the quarter under its buyback policy, with purchases at a significant discount to NAV adding value to NAV per share. The filing does not disclose the volume or total cost of those purchases.
The gap between portfolio performance and shareholder return is stark. Over three months, total shareholder return was negative 9.4%, despite the positive 0.9% adjusted NAV return. That divergence leaves the discount itself as one of the more consequential figures in the update, although narrowing it would depend on future share-price performance and the company’s ongoing capital-allocation activity.
Delegat and Vista lead quarterly contributors
Delegat was the strongest contributor, delivering a 21% total shareholder return during the quarter after reporting operating profit after tax of $61.5 million and guiding to $62 million to $66 million for its new financial year. Kingfish said the wine company continued to outperform the broader category, helped by consumer preference for premium brands such as Oyster Bay.
Vista rose 19%, while Fisher & Paykel Healthcare gained 18% after lifting guidance in August. Vulcan Steel and Mainfreight also advanced, by 8% and 7% respectively. Kingfish added Skellerup during the quarter, describing the manufacturer of technical polymer products as a diversified, globally exposed business focused on agriculture and industrial applications; the new holding had already contributed positively by quarter-end.
Summerset and Freightways expose softer economic conditions
Summerset was the largest named detractor, falling 14%. Kingfish’s manager said the retirement village operator had shifted towards balancing growth with stronger cash generation, a stronger balance sheet and greater operating discipline, but higher interest rates and political uncertainty were creating near-term pressure on house prices and unit sales.
Freightways fell 9% after reporting a 17% increase in earnings per share for the year to June, with its New Zealand courier operations showing weaker same-customer activity. Infratil declined 8% after earlier gains, although its September investor day included higher current-year core operating earnings guidance for CDC Data Centres and increased planned annual development by Longroad.
Dividend supports income focus as Skellerup enters portfolio
Kingfish paid a quarterly dividend of 2.50 cents per share on 25 September. Participation in the dividend reinvestment plan remained high at 37%, with reinvested shares issued at a 3% discount to the market price. The portfolio held 97.8% in equities and 2.2% in New Zealand dollar cash at quarter-end, with Fisher & Paykel Healthcare and Infratil the two largest positions.
Bottom Line?
Kingfish’s portfolio has gained ground over six months, but the 15.5% NAV discount shows that underlying asset performance has not yet translated into shareholder returns.
Questions in the middle?
- Can Kingfish’s buyback activity meaningfully reduce the 15.5% discount to NAV?
- Will the recent Skellerup addition become a larger portfolio position over coming quarters?
- Can Delegat, Vista and Fisher & Paykel Healthcare continue offsetting weakness in Summerset, Freightways and other economically sensitive holdings?